Cilazapril effect on left ventricular function and myocardial perfusion in patients with essential hypertension stage II

R. S. Karpov, E. N. Pavlyukova, T. D. Kapishchenko, V. I. Chernov

Research output: Contribution to journalArticlepeer-review

Abstract

22 patients (mean age 45.08 ± 1.38 years) with essential hypertension stage II were entered in a placebo-controlled blind trial of cilazapril, angiotensin-converting enzyme. A complex of clinical-instrumental tests comprised dipidamol test, bicycle ergometry, 199Tl myocardial scintigraphy, echo-CG. A 3-month course of cilazapril reduced myocardial hypoperfusion in 15 patients, improved left ventricular relaxation. Antiischemia effect of the drug was also evident.

Original languageEnglish
Pages (from-to)50-53
Number of pages4
JournalTerapevticheskii Arkhiv
Volume67
Issue number9
Publication statusPublished - 1995
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Cilazapril effect on left ventricular function and myocardial perfusion in patients with essential hypertension stage II'. Together they form a unique fingerprint.

Cite this